[ Price : $8.95]
FDA warns LifeHealth Science that its OR product is considered to be an unapproved and misbranded new drug and also violates dieta...[ Price : $8.95]
Federal Register notice: FDA announces its process for publishing FDA Emergency Use Authorizations for medical devices related to ...[ Price : $8.95]
FDA publishes interim levels of certain ethanol impurities that would be acceptable in hand sanitizers during the Covid-19 public ...[ Price : $8.95]
Amneal recalls all lots of metformin HCl extended-release tablets after FDA analysis finds unacceptable levels of NDMA.[ Price : $8.95]
Public Citizen says many organizations opposing plans to make Covid-19 treatments and vaccines affordable have received drug indus...[ Price : $8.95]
Two University of Pennsylvania medical school professors urge FDA to resist any efforts to rush an authorization for any Covid-19 ...[ Price : $8.95]
A Government Accountability Office official tells the Senate Finance Committee that the Covid-19 public health emergency is exacer...[ Price : $8.95]
FDA accepts for review a Y-mAbs Therapeutics BLA for Danyelza (naxitamab) for treating patients with relapsed/refractory high-risk...